Literature DB >> 12655275

Oxidative stress and regional ischemia-reperfusion injury: the peroxynitrite-poly(ADP-ribose) polymerase connection.

Lucas Liaudet1, Gábor Szabó, Csaba Szabó.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655275     DOI: 10.1097/00019501-200304000-00004

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


× No keyword cloud information.
  11 in total

1.  Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Béla Horváth; Sándor Bátkai; Ogyi Park; Galin Tanchian; Rachel Y Gao; Vivek Patel; David A Wink; Lucas Liaudet; György Haskó; Raphael Mechoulam; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2011-03-11       Impact factor: 7.376

Review 2.  Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Authors:  Nathan A Berger; Valerie C Besson; A Hamid Boulares; Alexander Bürkle; Alberto Chiarugi; Robert S Clark; Nicola J Curtin; Salvatore Cuzzocrea; Ted M Dawson; Valina L Dawson; György Haskó; Lucas Liaudet; Flavio Moroni; Pál Pacher; Peter Radermacher; Andrew L Salzman; Solomon H Snyder; Francisco Garcia Soriano; Robert P Strosznajder; Balázs Sümegi; Raymond A Swanson; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2017-03-26       Impact factor: 8.739

3.  A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.

Authors:  Bėla Horváth; Lital Magid; Partha Mukhopadhyay; Sándor Bátkai; Mohanraj Rajesh; Ogyi Park; Galin Tanchian; Rachel Y Gao; Catherine E Goodfellow; Michelle Glass; Raphael Mechoulam; Pál Pacher
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  Burn Injury-Associated MHCII+ Immune Cell Accumulation Around Lymphatic Vessels of the Mesentery and Increased Lymphatic Endothelial Permeability Are Blocked by Doxycycline Treatment.

Authors:  Walter E Cromer; Scott D Zawieja; Karen M Doersch; Hayden Stagg; Felicia Hunter; Binu Tharakan; Ed Childs; David C Zawieja
Journal:  Lymphat Res Biol       Date:  2018-01-23       Impact factor: 2.589

5.  Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes.

Authors:  B Pesse; S Levrand; F Feihl; B Waeber; B Gavillet; P Pacher; L Liaudet
Journal:  J Mol Cell Cardiol       Date:  2005-05       Impact factor: 5.000

6.  Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.

Authors:  Sándor Bátkai; Partha Mukhopadhyay; Bėla Horváth; Mohanraj Rajesh; Rachel Y Gao; Anu Mahadevan; Mukkanti Amere; Natalia Battista; Aron H Lichtman; Lisa A Gauson; Mauro Maccarrone; Roger G Pertwee; Pál Pacher
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 7.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

8.  The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.

Authors:  Gerwyn Morris; Michael Berk
Journal:  BMC Med       Date:  2015-04-01       Impact factor: 8.775

9.  Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?

Authors:  Peter Onody; Rita Stangl; Andras Fulop; Oliver Rosero; David Garbaisz; Zsolt Turoczi; Gabor Lotz; Zoltan Rakonczay; Zsolt Balla; Viktor Hegedus; Laszlo Harsanyi; Attila Szijarto
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

10.  Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).

Authors:  Gerwyn Morris; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.